The Current Ratio as of November 2024 (TTM) for Cyclo Therapeutics, Inc. (CYTH) is 0.45

According to Cyclo Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.45. This represents a change of -51.63% compared to the average of 0.94 of the last 4 quarters.

Cyclo Therapeutics, Inc. (CYTH) Historical Current Ratio (quarterly & annually)

How has CYTH Current Ratio performed in the past?

The mean historical Current Ratio of Cyclo Therapeutics, Inc. over the last ten years is 2.69. The current 0.45 Current Ratio has changed 1.59% with respect to the historical average. Over the past ten years (40 quarters), CYTH's Current Ratio was at its highest in in the September 2014 quarter at 13.04. The Current Ratio was at its lowest in in the June 2024 quarter at 0.45.

Cyclo Therapeutics, Inc. (CYTH) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Cyclo Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Cyclo Therapeutics, Inc. (CYTH) Average Current Ratio

How has CYTH Current Ratio performed in the past?

The current Current Ratio of Cyclo Therapeutics, Inc. (CYTH) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Cyclo Therapeutics, Inc. (CYTH) Current Ratio vs. Peers

How is CYTH’s Current Ratio compared to its peers?

Cyclo Therapeutics, Inc.’s Current Ratio is less than Athenex, Inc. (1.09), greater than MedMen Enterprises Inc. (0.19), less than Lifecore Biomedical, Inc. (1.83), greater than Lucy Scientific Discovery Inc. (0.38), less than Guardion Health Sciences, Inc. (16.67), less than Agile Therapeutics, Inc. (0.55), less than Alpha Teknova, Inc. (4.76), less than Petros Pharmaceuticals, Inc. (1.40), less than Phibro Animal Health Corporation (2.94), less than SOHM, Inc. (2.84), less than Silver Spike Investment Corp. (6.09), less than Eagle Pharmaceuticals, Inc. (1.70), less than Intra-Cellular Therapies, Inc. (7.66), less than Ironwood Pharmaceuticals, Inc. (3.92), less than Amneal Pharmaceuticals, Inc. (1.33), less than Aquestive Therapeutics, Inc. (7.49), less than Assertio Holdings, Inc. (1.93), less than AcelRx Pharmaceuticals, Inc. (4.04),

Build a custom stock screener for Cyclo Therapeutics, Inc. (CYTH) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cyclo Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cyclo Therapeutics, Inc. (CYTH) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cyclo Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.